These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21899211)

  • 1. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
    Yoshihara S; Fukuda H; Arisaka O
    Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
    Yoshihara S; Ono M; Yamada Y; Fukuda H; Abe T; Arisaka O
    Pediatr Allergy Immunol; 2009 Aug; 20(5):486-92. PubMed ID: 19210644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
    Kimata H
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate.
    Ishiura Y; Fujimura M; Yamamoto H; Nobata K; Ishiguro T; Ogawa H; Myou S
    Arzneimittelforschung; 2008; 58(6):297-302. PubMed ID: 18677972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
    Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
    Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
    Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
    J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
    Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
    Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
    Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
    Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group.
    Tamaoki J; Kondo M; Sakai N; Aoshiba K; Tagaya E; Nakata J; Isono K; Nagai A
    Lancet; 2000 Jul; 356(9226):273-8. PubMed ID: 11071181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
    Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
    Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory effect of suplatast tosilate on eosinophil migration].
    Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
    Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma.
    Shioya T; Satake M; Sano M; Kagaya M; Watanabe A; Sato K; Ito T; Ito N; Sasaki M; Miura M
    Eur J Clin Pharmacol; 2002 Jun; 58(3):171-6. PubMed ID: 12107601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
    Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate].
    Yamasawa H; Oshikawa K; Sugiyama Y
    Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
    Yoshida M; Aizawa H; Inoue H; Matsumoto K; Koto H; Komori M; Fukuyama S; Okamoto M; Hara N
    J Asthma; 2002 Sep; 39(6):545-52. PubMed ID: 12375715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma.
    Sano Y; Suzuki N; Yamada H; To Y; Ogawa C; Ohta K; Adachi M
    J Allergy Clin Immunol; 2003 May; 111(5):958-66. PubMed ID: 12743558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Add-on effects of suplatast tosilate in bronchial asthma patients treated with inhaled corticosteroids.
    Sano T; Nakamura Y; Yanagawa H; Bando H; Nii A; Yoshida S; Sone S;
    Lung; 2003; 181(4):227-35. PubMed ID: 14692563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells.
    Oda N; Minoguchi K; Tanaka A; Yokoe T; Minoguchi H; Matsuo H; Nakashima M; Tasaki T; Adachi M
    Clin Exp Allergy; 2002 Dec; 32(12):1782-6. PubMed ID: 12653172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic effectiveness of suplatast tosilate in children with asthma symptoms in the autumn: a pilot study.
    Yoshihara S; Yamada Y; Fukuda H; Tsuchiya T; Ono M; Fukuda N; Kanno N; Arisaka O
    Allergol Int; 2014 Jun; 63(2):199-203. PubMed ID: 24561769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kimura's disease treated with suplatast tosilate and loratadine.
    Ueda T; Arai S; Amoh Y; Katsuoka K
    Eur J Dermatol; 2011; 21(6):1020-1. PubMed ID: 21914581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.